Molecular Mechanisms, Immunogenetic Characteristics, Clinical and Therapeutical Consequences of the 21-hydroxylase Deficiency in the Latvian Children. Summary of the Doctoral Thesis

Gardovska, DaceDzīvīte-Krišāne, Iveta2023-08-082023-08-082011Dzīvīte-Krišāne, I. 2011. Molecular Mechanisms, Immunogenetic Characteristics, Clinical and Therapeutical Consequences of the 21-hydroxylase Deficiency in the Latvian Children: Summary of the Doctoral Thesis: Speciality – Paediatrics. Rīga: Rīga Stradiņš University. https://doi.org/10.25143/prom-rsu_2011-12_dts1–47https://dspace.rsu.lv/jspui/handle/123456789/14457The Doctoral Thesis was developed at the Children Clinical University Hospital in Riga (Clinical part of the Doctoral program); Riga Stradins University; the Children Endocrinology Centre and at the Endocrinology Scientific Laboratory of Karolinska Institute in Sweden, Stockholm (Experimental part). Defence: on 15th of March, 2011, at 15.00 during the Riga Stradins University Internal Medicine Doctorate Board meeting in the RSU Hipocrates auditorium, Riga, Dzirciema str. 16.ElectronicenAttribution-NonCommercial 4.0 Internationalinfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc/4.0/Summary of the Doctoral ThesisSector – Medicine; Speciality – PaediatricsMolecular Mechanisms, Immunogenetic Characteristics, Clinical and Therapeutical Consequences of the 21-hydroxylase Deficiency in the Latvian Children. Summary of the Doctoral Thesis21-hidroksilāzes deficīta molekulārie mehānismi, imūnģenētiskais raksturojums, to klīniskās un terapeitiskās konsekvences bērniem Latvijā. Promocijas darba kopsavilkumsinfo:eu-repo/semantics/otherhttps://doi.org/10.25143/prom-rsu_2011-12_dts